This is the 5th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies. Specifically, we’ll be discussing ATMP/CGT and Contamination Control strategies. You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts.

Learn about how ValSource can support your Annex 1 planning: https://valsource.com/annex1-gap-analysis/

In the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies, we’ll be discussing ATMP/CGT and working with third parties. You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts.

Learn about how ValSource can support your Annex 1 planning: https://valsource.com/annex1-gap-analysis/

Continue the ATMP discussion with our experts. This episode is focused on working with third parties, what regulations and expectations are out there now, and what might be coming around the corner. You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts.

Learn about how ValSource can support your Annex 1 planning: https://valsource.com/annex1-gap-analysis/

Listen & Learn – ValSource experts explore Phase Appropriate GMPs as they apply to Advanced Therapeutic Medical Products or ATMPs. You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts.

Learn about how ValSource can support your Annex 1 planning: https://valsource.com/annex1-gap-analysis/

Meet the Experts! The first episode in the Advanced Therapeutic Medicinal Products or ATMPs series, including Cell & Gene Therapies.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. Learn more about how ValSource can support your Annex 1 planning: https://valsource.com/annex1-gap-analysis/

Continue listening to our podcast series focused on Advanced Therapeutic Medical Products (ATMPs), including cell and gene therapies. Today’s topic is a look-back at the October 2021 ATMP/CGT meeting hosted by the PDA – Parenteral Drug Association – with our panel of experts Darius Pillsbury, Kelly Waldron, PhD, and Virginia Andreotti-Jones.

This is the 5th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies. Specifically, we’ll be discussing ATMP/CGT and Contamination Control strategies.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. To learn more about how ValSource can support you, visit www.valsource.com

In the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that include cell and gene therapies, we’ll be discussing ATMP/CGT and working with third parties.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. To learn more about how ValSource can support you, visit www.valsource.com

Continue the ATMP discussion with our experts. This episode is focused on working with third parties, what regulations and expectations are out there now, and what might be coming around the corner.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. To learn more about how ValSource can support you, visit www.valsource.com

Listen & Learn – ValSource experts explore Phase Appropriate GMPs as they apply to Advanced Therapeutic Medical Products or ATMPs.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. To learn more about how ValSource can support you, visit www.valsource.com

Meet the Experts! The first episode in the Advanced Therapeutic Medicinal Products or ATMPs series, including Cell & Gene Therapies.

You can tune into ValSource Viewpoints on Spotify, Apple Podcasts, & Google Podcasts. To learn more about how ValSource can support you, visit www.valsource.com